Background: We intend to assess the efficacies and limitations of collagenase clostridium
histolyticum (CCH) and fasciectomy in treating Dupuytren's contracture, and the associated …

This systematic review summarizes the outcome reporting standards in Dupuytren's disease
treatment research. A search of Ovid Medline, Ovid Embase, and CINAHL was conducted …

Background Collagenase clostridium histolyticum is now recognized as a viable treatment
for Dupuytren disease. The high rate of adverse effects reported in patients continues to …

Abstract Introduction Since March 2011, the microbial collagenase of Clostridium
histolyticum (Xiapex®, Swedish Orphan Biovitrum AB, Stockholm, Sweden) has become …

Purpose To study the efficacy of bupivacaine liposome injectable suspension in prolonging
sensory blocks of the median and ulnar nerves for subjects with Dupuytren contracture …

Background/Aims Understanding an individual's experience of living with Dupuytren's
disease is important to support rehabilitation. The aim of this review was to explore the …

The use of enzymatic fasciotomy with clostridium histolyticum collagenase for the
management of Dupuytren's contracture has progressively increased since its approval for …

DupuytrenLs disease is a benign fibromatosis that affects the palmar and digital fascia. The
pathology associated with the development of DupuytrenLs disease is the cause of some …

Introduction This study verified the effectiveness of oral prednisolone after collagenase
clostridium histolyticum (CCH)(10 mg/day for 2 weeks) for Dupuytren's contracture with a 1 …

Purpose To investigate multidimensional pain intensity and quality after collagenase
Clostridium histolyticum (CCH) injection in patients with Dupuytren contracture using a pain …